U.S. Capital Markets Stock News

NYSE:RS
NYSE:RSMetals and Mining

What Reliance (RS)'s U.S. Metals Acquisitions Amid Margin Pressures Means For Shareholders

Recently, Reliance, Inc. reported benefiting from firm end-market demand and a series of acquisitions that broaden its metals solutions capabilities and U.S. footprint, even as weaker semiconductor and commercial aerospace markets and higher aluminum and tariff-related costs weighed on margins. The interesting angle for investors is how these acquisitions deepen Reliance’s presence in select U.S. growth markets, potentially reshaping its mix toward higher-value services despite ongoing cost...
NasdaqCM:IMPP
NasdaqCM:IMPPOil and Gas

Oil And Gas Producers Worth Watching As Energy Prices And Inflation Stay In Focus

Oil and gas producers sit at the crossroads of several powerful forces right now, from a more uncertain Federal Reserve to renewed conflict in the Middle East and fresh inflation pressure linked to AI spending. That mix can shift earnings expectations, cash flows, and valuations quickly, especially for larger, financially healthy companies that are closely tied to energy prices. This article explains how those catalysts might matter for you as an investor and highlights 3 stocks from our Oil...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Teradyne (TER) Falls Following Insider Selling As Fair Value Debate Sharpens

Teradyne (TER) shares fell 5.1% on July 13, 2026, extending a decline of 10.1% over the past week and 15.4% over the last month, after signals of potential overvaluation and insider selling. See our latest analysis for Teradyne. Zooming out, Teradyne’s share price has a year to date return of 70.18% and a one year total shareholder return of 280.67%, suggesting strong long term momentum despite a 12.39% decline over the past month. If the recent volatility around Teradyne has you looking...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Teva Pharmaceutical Industries (TEVA) Advances TEV 408, Is The Stock Still Cheap?

Why TEV-408 Matters for Teva Pharmaceutical Industries Stock Teva Pharmaceutical Industries (NYSE:TEVA) has become a focus after the company said its investigational anti IL 15 antibody, TEV 408, will move into a Phase 2b vitiligo trial following encouraging Phase 1b data. For investors, this update puts Teva’s biopharma pipeline in the spotlight, since TEV 408 is being studied not only in vitiligo but also in celiac disease, where it already has U.S. FDA Fast Track status. See our latest...
NYSE:V
NYSE:VDiversified Financial

How Visa’s New AI Financial Assistant At Visa (V) Has Changed Its Investment Story

In early July 2026, Visa announced its AI Financial Assistant, a white-label, in-app conversational tool that lets banks offer AI-driven spending insights, card controls, and guided actions to cardholders without custom development. This launch, informed by Visa’s Data & AI Platform and hundreds of billions of annual transactions, positions the company’s network data as a core engine for bank-branded AI experiences rather than just transaction processing. We’ll now examine how Visa’s AI...
NYSE:HSY
NYSE:HSYFood

Is Hershey’s Texture-Driven REESE’S PIECES Relaunch a Meaningful Shift in HSY’s Snacking Strategy?

Earlier this month, The Hershey Company introduced REESE'S PIECES with Chocolate Cookie in the U.S., the brand's first new REESE'S PIECES product in a decade, featuring a crispy chocolate cookie center, creamy peanut butter flavor and the classic candy shell. This long-awaited twist on a core brand highlights Hershey's emphasis on texture-rich snacking and its focus on extending the REESE'S franchise into more everyday snacking occasions. Next, we'll examine how this long-awaited REESE'S...
NYSE:HIMS
NYSE:HIMSHealthcare

How Hims & Hers Health's (HIMS) Peptide Push Amid FDA Scrutiny Has Changed Its Investment Story

In recent days, Hims & Hers Health launched a consumer campaign promoting peptide therapies just as the FDA intensified scrutiny of several popular peptides over contamination risks and limited human evidence, ahead of an advisory committee meeting. This timing highlights a tension between the company’s push into new wellness categories and rising regulatory attention that could influence how its latest offerings are received by clinicians, regulators and consumers. Next, we’ll examine how...
NYSE:CWAN
NYSE:CWANSoftware

Is Clearwater Analytics Holdings (CWAN) Fully Valued Following The MSIG Europe Win?

MSIG Europe Expands Use of Clearwater Platform Clearwater Analytics Holdings (CWAN) drew fresh attention after MSIG Europe selected its platform to modernize investment operations, unify data across the investment lifecycle, and address European regulatory requirements. This new mandate follows prior deployments at MSIG’s Asia office and other business units, giving Clearwater Analytics additional exposure to the insurance sector and a broader foothold in European markets. See our latest...
NYSE:KR
NYSE:KRConsumer Retailing

Is Kroger (KR) Fairly Valued As It Pushes Freshness And Personalized Merchandising?

Kroger stock: people leadership shift and focus on freshness Kroger (KR) is drawing attention after appointing Emilee De Martino as Executive Vice President and Chief People Officer, while also stressing tighter freshness standards and item level merchandising across its grocery stores. For investors, this combination of leadership change and operational focus puts Kroger’s human capital and store level execution in the spotlight at the same time. The company is linking people strategy with...
NYSE:KBH
NYSE:KBHConsumer Durables

Is KB Home’s (KBH) Energy-Efficient West Coast Push Redefining Its Core Earnings Engine?

Earlier this week, KB Home opened several new communities, Meadowbrook in Campbell, Greyhawk and Sparrow at Dutton Meadows in Santa Rosa, and Tobiano in southwest Las Vegas, featuring ENERGY STAR®-designed, highly customizable homes with prices starting around US$400,000 to US$1.2 million and sales offices now accepting in-person and virtual tours. By expanding into high-demand West Coast and Las Vegas submarkets with energy-efficient, built-to-order homes, KB Home is reinforcing its focus...
NYSE:MTB
NYSE:MTBBanks

M&T Bank (MTB) Nears Earnings, Is The Stock Already Fully Valued?

M&T Bank (MTB) is back in focus as it prepares to report earnings this Wednesday before the bell, with investors watching whether revenue growth aligns with expectations after last quarter’s mixed performance. See our latest analysis for M&T Bank. M&T Bank’s recent share price momentum has been firm, with a 30-day share price return of 4.3% and an 18.53% year to date share price return. Longer term total shareholder returns of 26.24% over 1 year and 109.89% over 5 years show the stock has...
NYSE:BDX
NYSE:BDXMedical Equipment

3 Dividend Aristocrats Still Worth Watching As Rates Stay Higher For Longer

With Fed Chair Kevin Warsh signaling that interest rates may stay higher for longer, inflation still above the 2% target, and oil prices jumping after renewed tensions in the Strait of Hormuz, many investors are reassessing how reliable their income stocks really are. Dividend Aristocrats, with long records of raising payouts and a focus on financial discipline, can look appealing when volatility and inflation risks rise together. This article walks through 3 stocks from our Dividend...
NYSE:VSTS
NYSE:VSTSCommercial Services

Vestis (VSTS) Faces A Teamsters Strike, Is The Valuation Already Priced In?

Vestis (VSTS) is in focus after 29 workers represented by Teamsters Local 135 launched an unfair labor practice strike, citing alleged threats over protected concerted activity and seeking fair pay and improved benefits. See our latest analysis for Vestis. Vestis shares have been on a strong run, with a 30 day share price return of 12.96%, a 90 day share price return of 61.08%, and a year to date share price return of 126.44%. The 1 year total shareholder return of 148.75% suggests recent...
NYSE:FDS
NYSE:FDSCapital Markets

Is FactSet’s AI Pact With Google Cloud and Buybacks Altering The Investment Case For FDS?

In July 2026, FactSet Research Systems Inc. reported third‑quarter fiscal 2026 results showing higher sales of US$622.92 million but lower net income of US$126.72 million versus a year earlier, reaffirmed full‑year revenue and earnings guidance, and completed a US$505.96 million share repurchase program covering 5.55% of its stock. FactSet also announced a multi‑faceted AI partnership with Google Cloud aimed at embedding Gemini‑powered agents into its Workstation and expanding cloud...
NYSE:KVYO
NYSE:KVYOSoftware

Did Klaviyo’s (KVYO) New CFO Hire and AI CRM Push Just Reframe Its Growth Narrative?

Klaviyo, Inc. recently named former CyberArk CFO Erica Smith as its new Chief Financial Officer and principal financial and accounting officer, with outgoing CFO Amanda Whalen supporting the transition through an advisory role this year. Alongside this leadership update, Klaviyo has been rolling out AI-powered CRM capabilities and social marketing tools that more tightly connect customer data, automation, and omnichannel engagement for brands. Next, we will examine how Erica Smith’s...
NYSE:BBY
NYSE:BBYSpecialty Retail

Does Insider Selling and a Downgrade Recast Best Buy’s (BBY) Governance Story and Risk Profile?

In recent days, Loop Capital downgraded Best Buy to Hold, citing leadership transitions involving the new CEO Jason Bonfig and the CFO, rising operational risks, and a wave of insider sales, including planned disposals from the Richard M. Schulze Revocable Trust dating back to founder-era shares. These governance and insider-selling concerns arrive as Best Buy’s more diversified electronics and services model contrasts with GameStop’s challenged core gaming business, reshaping how investors...
NasdaqGS:APP
NasdaqGS:APPSoftware

Upstart Stock Leads 3 Fast Growing Names With Heavy Insider Ownership

With markets on edge over energy shocks, inflation data and shifting rate expectations, many investors are looking for companies where insiders have meaningful skin in the game and where growth expectations remain optimistic. The Fast Growing Stocks With High Insider Ownership screener focuses on exactly that combination, highlighting businesses where management and analysts both see room for expansion and leaders are heavily invested alongside you. This article introduces three stocks from...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

How Investors Are Reacting To Keurig Dr Pepper (KDP) Split Plan And Debt-Heavy Reshaping Strategy

Keurig Dr Pepper recently reported strong growth in its U.S. Refreshment Beverages segment, highlighted by brands such as Dr Pepper and GHOST energy, while outlining a plan to split into two pure-play companies targeting about US$400 million in cost savings despite carrying approximately US$25.90 billion of debt. An interesting angle is that Barclays has called out Keurig Dr Pepper as potentially materially undervalued, with the proposed company split and the push to grow GHOST’s energy...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story

BeOne Medicines Ltd. recently reported positive topline results from its Phase 3 MANGROVE trial, where BRUKINSA (zanubrutinib) plus rituximab significantly improved progression-free survival versus bendamustine plus rituximab in previously untreated mantle cell lymphoma. This is the first global Phase 3 study to show a chemotherapy-free, rituximab maintenance-free regimen can match or exceed standard chemoimmunotherapy, potentially sparing patients around two years of infusion treatment...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Will SLATE 3D Integration and SEALSQ Quantum Partnership Change GLOBALFOUNDRIES' (GFS) Competitive Narrative?

Earlier this month, SEALSQ Corp. announced a Memorandum of Understanding with GlobalFoundries to co-develop secure semiconductor platforms, Post-Quantum Cryptography solutions, and cryogenic ASICs, leveraging GlobalFoundries’ manufacturing and MIPS unit alongside SEALSQ’s security and quantum expertise to support U.S. and European supply chain goals. GlobalFoundries also reported that its SLATE wafer-to-wafer bonding technology is now production-ready on the 9SW RF-SOI platform in Singapore,...
NYSE:SNAP
NYSE:SNAPInteractive Media and Services

Snap (SNAP) Stock May Be A Bargain On New SPECS Glasses Launch

Snap stock is back in focus after a long slide, with the share price sharply lower over the past five years while some analysts now frame it as undervalued on traditional market multiples. That gap between weak historical returns and a more favorable pricing signal is what current investors need to weigh. Over the past 5 years, Snap shares have fallen about 92%, which leaves today’s valuation anchored on whether the business outlook has improved enough to justify a recovery case from a much...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Is Zscaler (ZS) Turning Zero Trust Everywhere Momentum Into a Durable Competitive Advantage?

In recent days, Zscaler highlighted strong enterprise uptake of its Zero Trust Everywhere cloud security platform, underscoring momentum across its broader security offerings. An important takeaway is that Zscaler’s focused Zero Trust expansion appears to contrast with rivals facing higher integration and cost burdens, potentially sharpening its competitive edge. Next, we’ll examine how accelerating Zero Trust Everywhere adoption could reshape Zscaler’s investment narrative and its...
NYSE:AFG
NYSE:AFGInsurance

American Financial Group (AFG) Faces Slower Growth And Falling Book Value

American Financial Group, NYSE:AFG, is drawing attention for slower growth in net premiums earned relative to insurance peers. Earnings per share growth has been modest, while book value per share has declined compared with other insurers. These trends are prompting closer scrutiny of the company’s fundamentals and positioning within the insurance sector. American Financial Group, NYSE:AFG, is coming under closer review as recent data shows slower growth in key operating metrics than many...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Intuitive Surgical (ISRG) Faces Recall Scrutiny, Is The Stock Still Cheap?

Intuitive Surgical (ISRG) is under closer scrutiny after a voluntary Class II recall of certain Da Vinci surgical system components, drawing investor attention to product quality controls and potential implications for the stock’s risk profile. See our latest analysis for Intuitive Surgical. Intuitive Surgical’s share price has come under pressure in recent months, with a 90 day share price return declining 12.86% and a year to date share price return down 27.56%. The 5 year total shareholder...